Table 5.

Characteristics and outcomes in patients who recurred on 3 year imaging

Patient No.	Age	Sex	Location of primary	Pathology	Location of metastatic disease	No. of months after 3year scans until symptoms	Additional therapy	No. of months after recurrence until death
1	50	F	Lower extremity	1.9 mm, 3 mit/mm2, CL IV, NU, Stage IIIA	Retroperitoneal, inguinal, pelvic LN	0.25	HD IL-2 Dacarbazine	6.5
2	70	F	Head and neck	1.33 mm, 15 mit/mm2, CL IV, NU, Stage IIIB	Lung, hemidiaphragm	0	None	1

Mit=mitoses, CL=Clark level, NU=non-ulcerated, LN=lymph nodes